IC & Hydroxyzine

 

IC & Hydroxyzine
Drug Information
Hydroxyzine is an antihistamine and mild anti-anxiety drug. It affects mast cell degranulation, which is thought to play a part in some interstitial cystitis (IC) patients’ symptoms, especially those who have a history of allergies, migraines and irritable bowel syndrome. Hydroxyzine has been shown to improve these conditions, as well as IC.

Hydroxyzine has been found to:

  • decrease nocturia (night time voiding)
  • decrease daytime frequency
  • decrease pain (burning, pressure, painful intercourse)

Hydroxyzine is available in the following two oral forms:

  • Generic name: hydroxyzine pamoate
    Brand name: Vistaril®
  • Generic name: hydroxyzine hydrochloride
    Brand name: Atarax®

Hydroxyzine pamoate (Vistaril) has a slightly higher absorption rate. Hydroxyzine-HCL is a liquid form available for patients allergic to fillers or dyes used in the capsules or pills.
 
Dosage
Most patients start with a 10 to 25 mg dosage of Atarax, Vistaril or their generic equivalent at bedtime every night for 1 week, and progress to 50 mg every night the second week. Ideally, within one month the dosage is increased to 75 mg, 50 mg taken at night and 25 mg taken during the day. Benefits of hydroxyzine may be seen within a few weeks to two months after initiating therapy. To decrease the sedating side effects, some patients start hydroxyzine therapy at a 10 mg dosage, available with Atarax or in the liquid form, and work their way up, gradually, to a maximum dosage of 50 – 75 mg After one year some patients are able to decrease their dosage by one-half without increasing symptoms. Others report that upon reducing their dosage, symptoms will return within a few days.

Side Effects

  • sedation
  • dry mouth
  • increased depression in patients diagnosed with concurrent depression

Self-Help Strategies
Take this medication early in the evening initially to avoid excessive morning drowsiness. Keep in mind that most patients report that any daytime drowsiness disappears within four to five days after beginning hydroxyzine therapy. Some patients report that with each dosage increase, the drowsiness period is shorter and not as intense.
 
Hydroxyzine Therapy and Pregnancy
Animal studies have found that fetal abnormalities occur at doses ten times higher than given to humans. It is not recommended that hydroxyzine be used if pregnant or nursing.

Other Antihistamines:
Some patients have reported a decrease in IC symptoms using other oral antihistamines, or medications with antihistamine properties, such as Claritin and Benadryl, or the newer leukotriene inhibitors such as Singulair. Hydroxyzine is contraindicated for use in epileptic patients.

Resources and References

  • Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, Hardy C, Landis JR, Mayer R, Madigan R, Messing EM, Peters K, Theoharides TC, Warren J, Wein AJ, Steers W, Kusek JW, Nyberg LM; Interstitial Cystitis Clinical Trials Group. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003 Sep;170(3):816-7.
  • Theoharides, TC, and Sant, G, Hydroxyzine Therapy for interstitial Cystitis. Urology: Interstitial Cystitis Supplement to May 1997, Alan J. Wein, MD & Philip M Hanno, MD, Editors, pp. 108-110.
  • Theoharides, TC, Hydroxyzine in the Treatment of Interstitial Cystitis, Urologic Clinics of North America: Interstitial Cystitis, Philip M. Hanno, MD, Editor, February, 1994, pp. 113-119.

Say your words